Curis Inc (CRIS) — Analysis Summary
Curis Inc (CRIS) has a market cap of $22.10M with year-over-year revenue growth of -13.4%. Net margin stands at -80.3%. The stock trades at a P/E ratio of -1.0.
Key Takeaways
- Revenue changed -13.4% year-over-year
- Net margin of -80.3%
- P/E ratio of -1.0
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, CRIS posted revenue growth of -13.4% and trades at a P/E of -1.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.